Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Post by Eastmkon Nov 08, 2021 6:45pm
108 Views
Post# 34102460

DermTech Melanoma Test available through DermatologistOnCall

DermTech Melanoma Test available through DermatologistOnCall

Using DermatologistOnCall's telemedicine platform is easy. To start the process, a patient uploads photos of a suspicious spot or mole to DermatologistOnCall for review by a U.S. boardcertified dermatologist. If the dermatologist determines that a DermTech Melanoma Test is warranted, they will order the Melanoma Test for the patient. The DermTech Adhesive Skin Collection Kit, which contains the DermTech Smart Sticker™, is sent to the patient’s home and the sample collection is conducted under virtual supervision by a DermatologistOnCall clinician. Any diagnosis or further treatment recommendation are based on the individual’s test results and the reviewing dermatologist’s medical judgment. Patients will be referred to a local physician for additional treatment as appropriate. From start to finish, the evaluation by a DermatologistOnCall Dermatologist and DermTech Melanoma Test results take an average of 10 days—a critical advantage for early detection, when compared to the average wait of approximately 35 days for a face-to-face dermatology appointment.

 

 
<< Previous
Bullboard Posts
Next >>